1,476
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Peritoneal transport status and first episode of peritonitis: a large cohort study

, &
Pages 1094-1103 | Received 05 Apr 2021, Accepted 17 Jun 2021, Published online: 07 Jul 2021

References

  • Piraino B, Bernardini J, Brown E, et a1. ISPD position statement on reducing the risks of peritoneal dialysis—related infections. Perit Dial Int. 2011;31(6):614–630.
  • Mehrotra R, Devuyst O, Davies SJ, et al. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238–3252.
  • Brown MC1, Simpson K, Kerssens JJ, et al. Peritoneal dialysis-associated peritonitis rates and outcomes in a national cohort are not improving in the post-millennium (2000–2007). Perit Dial Int. 2011;31(6):639–650.
  • Ye H, Zhou Q, Fan L, et al. The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients. BMC Nephrol. 2017;18(1):186.
  • Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–1405.
  • Ros S, Remon C, Qureshi AR, et al. Increased risk of fatal infections in women starting peritoneal dialysis. Perit Dial Int. 2013;33(5):487–494.
  • Nessim SJ, Bargman JM, Austin PC, et al. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol. 2009;4(7):1195–1200.
  • Lim WH, Boudville N, McDonald SP, et al. Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant. 2011;26(10):3366–3372.
  • Ghali JR, Bannister KM, Brown FG, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011;31(6):651–662.
  • Lim WH, Johnson DW, McDonald SP. Higher rate and earlier peritonitis in Aboriginal patients compared to non-aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Nephrology (Carlton). 2005;10(2):192–197.
  • McDonald SP, Collins JF, Rumpsfeld M, et al. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int. 2004;24(4):340–346.
  • Cho Y, Badve SV, Hawley CM, et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-center registry study. BMC Nephrol. 2012;13(1):41.
  • Kerschbaum J, Konig P, Rudnicki M. Risk factors associated with peritoneal-dialysis-related peritonitis. Int J Nephrol. 2012;2012:483250.
  • Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol. 2006;17(1):271–278.
  • Brimble KS, Walker M, Margetts PJ, et al. Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. JASN. 2006;17(9):2591–2598.
  • So S, Aw L, Sud K, et al. Membrane transport status does not predict peritonitis risk in patients on peritoneal dialysis. Nephrology (Carlton). 2018;23(7):633–639.
  • Gołembiewska E, Safranow K, Kabat-Koperska J, et al. Solute transport at the start of peritoneal dialysis and the risk of peritonitis. Adv Clin Exp Med. 2013;22(1):77–83.
  • Li PK1, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010;30(4):393–423.
  • Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Int. 1987;7(3):138–147.
  • Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–398.
  • Fan X, Huang R, Wang J, et al. Risk factors for the first episode of peritonitis in southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One. 2014;9(9):e107485.
  • Wang Q, Bernardini J, Piraino B, et al. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis. 2003;41(3):664–669.
  • Chow KM, Szeto CC, Leung CB, et al. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int. 2005;25(4):374–379.
  • Wu H, Huang R, Yi C, et al. Risk factors for early-onset peritonitis in Southern Chinese peritoneal dialysis patients. Perit Dial Int. 2016;36(6):640–646.
  • Tian Y, Xie X, Xiang S, et al. Risk factors and outcomes of early-onset peritonitis in Chinese peritoneal dialysis patients. Kidney Blood Press Res. 2017;42(6):1266–1276.
  • Iglesias J, Abernethy VE, Wang Z, et al. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol. 1999;277(5):F711–F722.
  • Wang HH, Lin CY, Huang TP. Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant. 2003;18(6):1181–1189.
  • Chen JHC, Johnson DW, Hawley C, Boudville N, et al. Association between causes of peritoneal dialysis technique failure and all-cause mortality. Sci Rep. 2018;8(1):3980. 5
  • Pongskul C, Sirivongs D, Keobounma T, et al. Survival and technical failure in a large cohort of Thai CAPD patients. Med Assoc Thai. 2006;89 (Suppl (2):S98–S105.
  • Sumi Y, Sakai Y, Mugishima K, et al. Current practice and outcomes of peritoneal dialysis in the Nippon Medical School Musashi Kosugi Hospital. J Nippon Med Sch. 2018;85(2):102–109.
  • Kalantar-Zadeh K, Cano NJ, Budde K, et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol. 2011;7(7):369–384.
  • Cano N, Fiaccadori E, Tesinsky P, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006;25(2):295–310.
  • Zhang F, Liu H, Gong X, et al. Risk factors for mortality in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2015;35(2):199–205.
  • Troidle L, Finkelstein F, Treatment and outcome of CPD associated peritonitis. Ann Clin Microbiol Antimicrob. 2006;5:6.
  • Cao XY, Zhou JH, Cai GY, et al. Predicting one-year mortality in peritoneal dialysis patients: an analysis of the China Peritoneal Dialysis Registry. Int J Med Sci. 2015;12(4):354–361. 1
  • Ning LN, Shang J, Zhao JF, et al. Risk of first-onset peritonitis in peritoneal dialysis patients. Chin Gen Pract. 2018;1(12):150–153.
  • Chang TI, Kang EW, Lee YK, et al. Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient. PLoS One. 2013;8(2):e56223.
  • Cooper S, Iliescu EA, Morton AR. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients. Adv Perit Dial. 2001;17:244–247.
  • Kim SB, Yang WS, Kang ES, et al. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease. Perit Dial Int. 1997;17(3):236–242.
  • Yang WS, Min WK, Park JS, et al. Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD. Am J Kidney Dis. 1997;30:507–513.
  • Davies SJ. Peritoneal solute transport and inflammation. Am J Kidney Dis. 2014;64(6):978–986.
  • Tonbul Z, Altintepe L, Sozlu C, et al. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int. 2003;23(1):46–52.
  • Aşci G, Ozkahya M, Duman S, et al. Volume control associated with better cardiac function in long-term peritoneal dialysis patients. Perit Dial Int. 2006;26(1):85–88.
  • Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States renal data system database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis. 2005;45(2):372–380.
  • Vlaanderen K, de Fijter CW, Bos HJ, et al. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients. Adv Perit Dial. 1989;5:151–153.
  • Ozener C, Arikan H, Karayaylali I, et al. The impact of diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study. Ren Fail. 2014;36(2):149–153.
  • Dong J, Chen Y, Luo S, et al. Peritoneal protein leakage, systemic inflammation, and peritonitis risk in patients on peritoneal dialysis. Perit Dial Int. 2013;33(3):273–279.
  • Chan HW, Clayton PA, McDonald SP, Agar JW, et al. Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry, 1999–2008. CJASN. 2012;7(5):775–781.
  • Birmelé B, Francois M, Pengloan J, et al. Death after withdrawal from dialysis: the most common cause of death in a French dialysis population. Nephrol Dial Transplant. 2004;19(3):686–691.
  • Chern YB, Ho PS, Kuo LC, et al. Lower education level is a major risk factor for peritonitis incidence in chronic peritoneal dialysis patients: a retrospective cohort study with 12-year follow-up. Perit Dial Int. 2013;33(5):552–558.